In addition, we identified natural small molecule drugs that can target liquid–liquid phase separation of core target proteins (PLK1 and TOP2A) by molecular docking, and finally verified that knockdown of MAPT can inhibit the proliferation and invasion of HCC by in vitro experiments. This evidence concerns the gene PLK1 and hepatocellular carcinoma.